CYTK
Cytokinetics, Incorporated$63.10+0.11 (+0.17%)Prev Close$62.99·MCap$8.76B·P/E—·Vol515.8K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
81
$53.02M
◆
Net Activity
Net Seller
$53.02M
●
Active Insiders
10
last 12 mo
Over the past 12 months, insider activity at Cytokinetics, Incorporated (CYTK) has been exclusively selling, with 0 insider purchases totaling $0.00 and 81 insider sales totaling $53.02M. The most recent insider transaction was by Malik Fady Ibraham (officer: EVP Research & Development), who sold $224.0K worth of shares on Oct 20, 2026. Cytokinetics, Incorporated operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $8.76B.
CYTK Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 20, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $64.01 | $224.0K | 153,902 |
| Oct 13, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $62.88 | $471.6K | 278,544 |
| Oct 6, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $61.38 | $214.8K | 153,902 |
| Sep 28, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $65.46 | $490.9K | 278,544 |
| Sep 22, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $68.29 | $239.0K | 153,902 |
| Sep 15, 2026 | Landry Robert E | director | Sell | 1,000 | $72.13 | $72.1K | 8,184 |
| Sep 15, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 105,426 | $69.62 | $7.34M | 377,820 |
| Sep 11, 2026 | Landry Robert E | director | Sell | 1,000 | $74.66 | $74.7K | 9,184 |
| Sep 8, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $75.46 | $264.1K | 153,902 |
| Sep 1, 2026 | PARSHALL B LYNNE | director | Sell | 5,000 | $71.48 | $357.4K | 10,784-32% |
| Aug 31, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $70.24 | $526.8K | 377,820 |
| Aug 31, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 10,000 | $70.24 | $702.4K | 58,555 |
| Aug 18, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $75.82 | $265.4K | 153,902 |
| Aug 10, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $76.76 | $575.7K | 377,820 |
| Jul 30, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 14,000 | $79.88 | $1.12M | 58,555 |
| Jul 27, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $80.87 | $606.5K | 377,820 |
| Jul 23, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $80.59 | $282.1K | 153,902 |
| Jul 14, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,490 | $82.02 | $614.3K | 377,820 |
| Jul 7, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $86.62 | $303.2K | 153,902 |
| Jul 2, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $84.92 | $636.9K | 377,830 |
| Jul 2, 2026 | Lee Sung | officer: EVP, Chief Financial Officer | Sell | 1,112 | $87.79 | $97.6K | 63,221 |
| Jul 2, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 15,000 | $85.80 | $1.29M | 58,555 |
| Jun 29, 2026 | Lee Sung | officer: EVP, Chief Financial Officer | Sell | 41,864 | $82.50 | $3.45M | 63,221-40% |
| Jun 23, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $79.51 | $278.3K | 153,902 |
| Jun 15, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $70.46 | $528.5K | 385,330 |
| Jun 9, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $67.98 | $237.9K | 153,902 |
| Jun 1, 2026 | PARSHALL B LYNNE | director | Sell | 5,000 | $74.08 | $370.4K | 15,784 |
| Jun 1, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 15,000 | $74.08 | $1.11M | 58,555 |
| Jun 1, 2026 | Kaye Edward M. MD | director | Sell | 2,933 | $76.09 | $223.2K | 10,283 |
| May 28, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $77.21 | $579.1K | 392,830 |
| May 20, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $75.69 | $264.9K | 153,902 |
| May 14, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $77.92 | $584.4K | 400,330 |
| May 5, 2026 | Lee Sung | officer: EVP, Chief Financial Officer | Sell | 23,906 | $76.87 | $1.84M | 63,221-27% |
| May 5, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 11,333 | $77.25 | $875.5K | 58,555 |
| May 5, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $77.37 | $270.8K | 153,902 |
| May 5, 2026 | HENDERSON JOHN T | director | Sell | 20,000 | $75.97 | $1.52M | 75,237 |
| May 5, 2026 | WIERENGA WENDELL | director | Sell | 4,032 | $75.00 | $302.4K | 32,637 |
| May 4, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 15,857 | $65.00 | $1.03M | 58,555 |
| Apr 30, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 15,000 | $63.26 | $948.9K | 58,555 |
| Apr 29, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $59.62 | $447.1K | 407,830 |
| Apr 21, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $65.69 | $229.9K | 153,902 |
| Apr 15, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $65.38 | $490.4K | 415,330 |
| Apr 15, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 7,449 | $66.02 | $491.8K | 58,555 |
| Apr 8, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 4,500 | $65.11 | $293.0K | 153,902 |
| Apr 1, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $66.63 | $499.7K | 422,830 |
| Mar 31, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 3,639 | $65.00 | $236.5K | 66,004 |
| Mar 18, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 36,601 | $62.15 | $2.27M | 454,258 |
| Mar 18, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 10,472 | $62.14 | $650.7K | 78,185 |
| Mar 18, 2026 | Lee Sung | officer: EVP, Chief Financial Officer | Sell | 4,935 | $62.15 | $306.7K | 87,127 |
| Mar 18, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 12,033 | $62.15 | $747.9K | 158,299 |
Showing 1–50 of 383
1 / 8
...
CYTK Insider Buying Activity
The following table shows recent insider purchases of Cytokinetics, Incorporated (CYTK) stock reported via SEC Form 4 filings.
No insider buying activity found for CYTK in the last 12 months.
CYTK Insider Selling Activity
The following table shows recent insider sales of Cytokinetics, Incorporated (CYTK) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 20, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $64.01 | $224.0K | 153,902 |
| Oct 13, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $62.88 | $471.6K | 278,544 |
| Oct 6, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $61.38 | $214.8K | 153,902 |
| Sep 28, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $65.46 | $490.9K | 278,544 |
| Sep 22, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $68.29 | $239.0K | 153,902 |
| Sep 15, 2026 | Landry Robert E | director | Sell | 1,000 | $72.13 | $72.1K | 8,184 |
| Sep 15, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 105,426 | $69.62 | $7.34M | 377,820 |
| Sep 11, 2026 | Landry Robert E | director | Sell | 1,000 | $74.66 | $74.7K | 9,184 |
| Sep 8, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $75.46 | $264.1K | 153,902 |
| Sep 1, 2026 | PARSHALL B LYNNE | director | Sell | 5,000 | $71.48 | $357.4K | 10,784-32% |
| Aug 31, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $70.24 | $526.8K | 377,820 |
| Aug 31, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 10,000 | $70.24 | $702.4K | 58,555 |
| Aug 18, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $75.82 | $265.4K | 153,902 |
| Aug 10, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $76.76 | $575.7K | 377,820 |
| Jul 30, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 14,000 | $79.88 | $1.12M | 58,555 |
| Jul 27, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $80.87 | $606.5K | 377,820 |
| Jul 23, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $80.59 | $282.1K | 153,902 |
| Jul 14, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,490 | $82.02 | $614.3K | 377,820 |
| Jul 7, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $86.62 | $303.2K | 153,902 |
| Jul 2, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $84.92 | $636.9K | 377,830 |
| Jul 2, 2026 | Lee Sung | officer: EVP, Chief Financial Officer | Sell | 1,112 | $87.79 | $97.6K | 63,221 |
| Jul 2, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 15,000 | $85.80 | $1.29M | 58,555 |
| Jun 29, 2026 | Lee Sung | officer: EVP, Chief Financial Officer | Sell | 41,864 | $82.50 | $3.45M | 63,221-40% |
| Jun 23, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $79.51 | $278.3K | 153,902 |
| Jun 15, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $70.46 | $528.5K | 385,330 |
| Jun 9, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $67.98 | $237.9K | 153,902 |
| Jun 1, 2026 | PARSHALL B LYNNE | director | Sell | 5,000 | $74.08 | $370.4K | 15,784 |
| Jun 1, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 15,000 | $74.08 | $1.11M | 58,555 |
| Jun 1, 2026 | Kaye Edward M. MD | director | Sell | 2,933 | $76.09 | $223.2K | 10,283 |
| May 28, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $77.21 | $579.1K | 392,830 |
| May 20, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $75.69 | $264.9K | 153,902 |
| May 14, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $77.92 | $584.4K | 400,330 |
| May 5, 2026 | Lee Sung | officer: EVP, Chief Financial Officer | Sell | 23,906 | $76.87 | $1.84M | 63,221-27% |
| May 5, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 11,333 | $77.25 | $875.5K | 58,555 |
| May 5, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $77.37 | $270.8K | 153,902 |
| May 5, 2026 | HENDERSON JOHN T | director | Sell | 20,000 | $75.97 | $1.52M | 75,237 |
| May 5, 2026 | WIERENGA WENDELL | director | Sell | 4,032 | $75.00 | $302.4K | 32,637 |
| May 4, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 15,857 | $65.00 | $1.03M | 58,555 |
| Apr 30, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 15,000 | $63.26 | $948.9K | 58,555 |
| Apr 29, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $59.62 | $447.1K | 407,830 |
| Apr 21, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 3,500 | $65.69 | $229.9K | 153,902 |
| Apr 15, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $65.38 | $490.4K | 415,330 |
| Apr 15, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 7,449 | $66.02 | $491.8K | 58,555 |
| Apr 8, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 4,500 | $65.11 | $293.0K | 153,902 |
| Apr 1, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 7,500 | $66.63 | $499.7K | 422,830 |
| Mar 31, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 3,639 | $65.00 | $236.5K | 66,004 |
| Mar 18, 2026 | Blum Robert I | director, officer: President & CEO | Sell | 36,601 | $62.15 | $2.27M | 454,258 |
| Mar 18, 2026 | Callos Andrew | officer: EVP, Chief Commercial Officer | Sell | 10,472 | $62.14 | $650.7K | 78,185 |
| Mar 18, 2026 | Lee Sung | officer: EVP, Chief Financial Officer | Sell | 4,935 | $62.15 | $306.7K | 87,127 |
| Mar 18, 2026 | Malik Fady Ibraham | officer: EVP Research & Development | Sell | 12,033 | $62.15 | $747.9K | 158,299 |
CYTK Insiders
Similar Stocks to CYTK
MRNA
Moderna, Inc.
$225.82+1.80%
$85.50B
REGN
Regeneron Pharmaceuticals, Inc.
$969.36+4.43%
$83.15B
RVMD
Revolution Medicines, Inc.
$190.88-0.20%
$39.42B
ALNY
Alnylam Pharmaceuticals, Inc.
$161.00-2.49%
$30.46B
UTHR
United Therapeutics Corporation
$595.67-0.51%
$25.15B
INCY
Incyte Corporation
$119.31-1.01%
$23.69B
INSM
Insmed Incorporated
$111.22-1.20%
$21.18B
EXEL
Exelixis, Inc.
$71.60+3.14%
$16.64B